304 related articles for article (PubMed ID: 35758326)
1. Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
Sharma M; Bellio MA; Benny M; Kulandavelu S; Chen P; Janjindamai C; Han C; Chang L; Sterling S; Williams K; Damianos A; Batlahally S; Kelly K; Aguilar-Caballero D; Zambrano R; Chen S; Huang J; Wu S; Hare JM; Schmidt A; Khan A; Young K
Stem Cells Transl Med; 2022 Aug; 11(8):828-840. PubMed ID: 35758326
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia.
Porzionato A; Zaramella P; Dedja A; Guidolin D; Bonadies L; Macchi V; Pozzobon M; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L688-L704. PubMed ID: 33502939
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppress Hyperoxia-Induced Transdifferentiation of Rat Alveolar Type 2 Epithelial Cells.
Ai D; Shen J; Sun J; Zhu Z; Gao R; Du Y; Yuan L; Chen C; Zhou J
Stem Cells Dev; 2022 Feb; 31(3-4):53-66. PubMed ID: 34913742
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles From Mesenchymal Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of Bronchopulmonary Dysplasia.
Bisaccia P; Magarotto F; D'Agostino S; Dedja A; Barbon S; Guidolin D; Liboni C; Angioni R; De Lazzari G; Caicci F; Viola A; Jurga M; Kundrotas G; Stevens D; Mancuso D; Gramegna E; Seitaj B; Kashyap R; De Vos B; Macchi V; Baraldi E; Porzionato A; De Caro R; Muraca M; Pozzobon M
Stem Cells Transl Med; 2024 Jan; 13(1):43-59. PubMed ID: 37963808
[TBL] [Abstract][Full Text] [Related]
7. Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia.
Porzionato A; Zaramella P; Dedja A; Guidolin D; Van Wemmel K; Macchi V; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L6-L19. PubMed ID: 30284924
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia.
Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S
Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model.
Crain SK; Robinson SR; Thane KE; Davis AM; Meola DM; Barton BA; Yang VK; Hoffman AM
Stem Cells Dev; 2019 Feb; 28(3):212-226. PubMed ID: 30412034
[TBL] [Abstract][Full Text] [Related]
10. All but Small: miRNAs from Wharton's Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration.
Tscherrig V; Steinfort M; Haesler V; Surbek D; Schoeberlein A; Joerger-Messerli MS
Cells; 2024 Mar; 13(6):. PubMed ID: 38534387
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis.
Chinnici CM; Iannolo G; Cittadini E; Carreca AP; Nascari D; Timoneri F; Bella MD; Cuscino N; Amico G; Carcione C; Conaldi PG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669517
[TBL] [Abstract][Full Text] [Related]
13. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
[TBL] [Abstract][Full Text] [Related]
14. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
[TBL] [Abstract][Full Text] [Related]
15. Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy.
Tang XL; Nasr M; Zheng S; Zoubul T; Stephan JK; Uchida S; Singhal R; Khan A; Gumpert A; Bolli R; Wysoczynski M
Stem Cell Rev Rep; 2023 Oct; 19(7):2429-2446. PubMed ID: 37500831
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
17. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury.
Ahn SY; Park WS; Kim YE; Sung DK; Sung SI; Ahn JY; Chang YS
Exp Mol Med; 2018 Apr; 50(4):1-12. PubMed ID: 29650962
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
